KwdFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « KwdFr.i » - entrée « Anticorps monoclonaux d'origine murine (usage thérapeutique) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anticorps monoclonaux d'origine murine (pharmacologie) < Anticorps monoclonaux d'origine murine (usage thérapeutique) < Anticorps monoclonaux humanisés  Facettes :

List of bibliographic references indexed by Anticorps monoclonaux d'origine murine (usage thérapeutique)

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]
Ident.Authors (with country if any)Title
001E22 (2015) Zden K Adam ; Petr Szturz ; Renata Koukalová ; Zden K Ehák ; Lud K Pour ; Marta Krej ; Lenka Šmardová ; Michal Eid ; Pavlína Volfová ; Zde Ka Ermáková ; Leoš K En ; Filip Sokol ; Ivo Hanke ; Eva Michalková ; Zden K Král ; Ji Mayer[PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].
001E29 (2015) Michael Scharl ; Dominik Schaer ; Florence Vallelian[CME. Biologics in vasculitis].
002262 (2014) M. Fleck ; P M Aries [Allemagne] ; C. Iking-Konert[Vasculitis: update 2014].
002264 (2014) Katsuichi Miyamoto[Topics of neuromyelitis optica].
002287 (2014) Fabrizio Cantini [Italie] ; Laura Niccoli ; Delia GolettiTuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries.
002338 (2014) Ennio Giulio Favalli [Italie] ; Martina Biggioggero [Italie] ; Antonio Marchesoni [Italie] ; Pier Luigi Meroni [Italie]Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
002364 (2014) Alison Clifford [États-Unis] ; Gary S. HoffmanRecent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies.
002366 (2014) E. Bizzi [Oman] ; U. Massafra ; B. Laganà ; V. Bruzzese ; A Picchianti Diamanti ; M. Cassol ; A. MiglioreRadiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review.
002372 (2014) Claire I. Daïen [France] ; Jacques Morel [France]Predictive Factors of Response to Biological Disease Modifying Antirheumatic Drugs: Towards Personalized Medicine
002390 (2014) Christiana Smith [États-Unis] ; Cathy Lee-Miller [États-Unis] ; Megan K. Dishop [États-Unis] ; Carrye Cost [États-Unis] ; Michael Wang [États-Unis] ; Edwin J. Asturias [États-Unis]Multicentric Castleman disease presenting with fever.
002494 (2014) Francesco Caso [Italie] ; Luisa Costa [Italie] ; Donato Rigante [Italie] ; Orso Maria Lucherini [Italie] ; Paolo Caso [Italie] ; Vittoria Bascherini [Italie] ; Bruno Frediani [Italie] ; Rolando Cimaz [Italie] ; Edoardo Marrani [Italie] ; Laura Nieves-Martín [Espagne] ; Mariangela Atteno [Italie] ; Carmela G L. Raffaele [Italie] ; Giusyda Tarantino [Italie] ; Mauro Galeazzi [Italie] ; Leonardo Punzi [Italie] ; Luca Cantarini [Italie]Biological treatments in Behçet's disease: beyond anti-TNF therapy.
002495 (2014) Lucía Silva-Fernández [Espagne] ; Estíbaliz Loza [Espagne] ; Víctor M. Martínez-Taboada [Espagne] ; Ricardo Blanco [Espagne] ; I Igo Rúa-Figueroa [Espagne] ; José María Pego-Reigosa [Espagne] ; Santiago Mu Oz-Fernández [Espagne]Biological therapy for systemic vasculitis: a systematic review.
002516 (2014) Sudipto Das [Royaume-Uni] ; Edward M. Vital ; Sarah Horton ; Domini Bryer ; Yasser El-Sherbiny ; Andrew C. Rawstron ; Frederique Ponchel ; Paul Emery ; Maya H. BuchAbatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.
002552 (2014) Monika Stensen [Norvège]Safety issues of biologics in pregnant patients with rheumatic diseases
002642 (2013) M. Fleck ; B. Hellmich[Vasculitis].
002661 (2013) Matthew L. Stoll [États-Unis] ; Randy Q. CronTreatment of juvenile idiopathic arthritis in the biologic age.
002682 (2013) Xavier Puéchal [France] ; Loïc GuillevinTherapeutic immunomodulation in systemic vasculitis: taking stock.
002713 (2013) Meliha Crnkic Kapetanovic ; Tore Saxne ; Göran Jönsson ; Lennart Truedsson ; Pierre GeborekRituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
002714 (2013) R J Maneiro [Espagne] ; Eva Salgado ; Loreto Carmona ; Juan J. Gomez-ReinoRheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis.
002738 (2013) Sebastian Unizony [États-Unis] ; John H. Stone ; James R. StoneNew treatment strategies in large-vessel vasculitis.
002753 (2013) Ilya Ayzenberg [Allemagne] ; Ingo Kleiter ; Alexandra Schröder ; Kerstin Hellwig ; Andrew Chan ; Takashi Yamamura ; Ralf GoldInterleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Anticorps monoclonaux d'origine murine (usage thérapeutique)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Anticorps monoclonaux d'origine murine (usage thérapeutique)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Anticorps monoclonaux d'origine murine (usage thérapeutique)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021